Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2000, p. 3882-3886, Vol. 38, No. 10
Microbiology, "L. Sacco" Teaching
Hospital, Milan,1 and Scientific
Affairs, Abbott Diagnostics Division, Rome,2
Italy
Received 24 April 2000/Returned for modification 6 June
2000/Accepted 17 July 2000
A new quantitative reverse transcription (RT)-PCR assay for human
immunodeficiency virus type 1 (HIV-1) RNA (Abbott LCx HIV RNA
Quantitative assay) has been compared with the Organon NucliSens assay
on 521 retrospective samples obtained from HIV-1-positive patients
monitored during highly active antiretroviral therapy, 79 of whom were
assayed also by the Chiron Quantiplex 3.0 system and on characterized
panels. The LCx system showed a moderate correlation
(r = 0.795) and gave higher results than the NucliSens system on 245 of 327 concordant positive samples, with similar sensitivity. Correlation with Quantiplex system results was higher (r = 0.943). LCx reproducibility was very good; the
procedure was simple, well controlled, and rapid (up to 48 results in
7 h). The HIV RNA quantitative assay on the LCx system is suitable for routine use.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evaluation of the Abbott LCx HIV-1 RNA Quantitative, a New
Assay for Quantitative Determination of Human Immunodeficiency
Virus Type 1 RNA
*
Corresponding author. Mailing address: Microbiologia,
Ospedale "Luigi Sacco," Via G. B. Grassi 74, 20175 Milano,
Italy. Phone: 39-02-39042479. Fax: 39-02-39042313. E-mail:
microbio{at}mailserver.unimi.it.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|